What the current U.S. label says
The current U.S. generic isotretinoin label includes tinnitus and hearing impairment under hearing-related adverse reactions. Its Medication Guide uses the plain phrase "ringing in your ears." Accutane is a familiar name for oral isotretinoin, but the evidence here comes from a current generic label rather than a formulation-specific risk estimate for the former brand.
Reported does not mean proven
Impaired hearing has been reported in people taking isotretinoin. The label also says the mechanism and causality for that reaction have not been established. In other words, a hearing problem reported during treatment does not settle why it happened in any one person.
What to do if ringing starts
If you develop ringing in your ears or your hearing gets worse while taking isotretinoin, stop taking isotretinoin and tell your healthcare provider. That is the Medication Guide's direct instruction. The label does not provide a personal dose-change or restart plan for this situation.
How common is it?
The label does not give a numerical tinnitus rate. It explains that some adverse reactions came from voluntary reports in a population of uncertain size, so their frequency may not be reliably estimated and a causal relationship to the drug may not be established.
What the persistence warning means
Some reports described hearing impairment that persisted after isotretinoin was stopped, and the Medication Guide warns that hearing loss may be permanent. That wording concerns hearing impairment or hearing loss. It does not establish that tinnitus itself will be permanent.
When it becomes an emergency
Sudden hearing loss or sudden deafness is a medical emergency: visit a doctor immediately. The isotretinoin label says to stop the medicine and tell your healthcare provider for ringing in the ears or worsening hearing. Sudden hearing loss or sudden deafness needs an immediate doctor visit.
Frequently asked questions
Can Accutane cause ringing in the ears?
Ringing in the ears is listed in current U.S. isotretinoin labeling, but that listing does not prove the medicine caused it. The label supports describing tinnitus as listed or reported during treatment.
How common is tinnitus with isotretinoin?
The current U.S. label does not give a numerical tinnitus rate. It warns that the frequency of some adverse reactions may not be reliably estimated from voluntary reports.
Should I stop isotretinoin if my ears start ringing?
Yes—the Medication Guide says to stop taking isotretinoin and tell your healthcare provider if you have ringing in your ears or worsening hearing. It does not provide a personal restart or dose-adjustment plan.
Is tinnitus while taking isotretinoin an emergency?
The Medication Guide says to stop isotretinoin and tell your healthcare provider for ringing in the ears or worsening hearing. Sudden hearing loss or sudden deafness needs an immediate doctor visit.
Can tinnitus from isotretinoin be permanent?
The label does not establish that tinnitus is permanent. Its persistence warning concerns hearing impairment or hearing loss in some reports, not a tinnitus-specific prognosis.
Sources
- ISOTRETINOIN capsules, for oral use — Full Prescribing Information and Medication Guide DailyMed, U.S. National Library of Medicine
- Sudden Sensorineural Hearing Loss (SSHL) National Institute on Deafness and Other Communication Disorders, National Institutes of Health